ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 115 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $120,541,385 | -29.2% | 26,204,649 | -0.6% | 0.11% | -24.1% |
| Q2 2023 | $170,316,292 | +13.9% | 26,364,751 | +33.0% | 0.14% | +7.4% |
| Q1 2023 | $149,515,570 | -25.1% | 19,829,651 | +0.7% | 0.14% | -35.1% |
| Q4 2022 | $199,527,925 | +51.0% | 19,696,735 | +47.5% | 0.21% | +52.9% |
| Q3 2022 | $132,109,000 | -7.1% | 13,357,668 | +0.0% | 0.14% | -6.8% |
| Q2 2022 | $142,227,000 | +32.0% | 13,354,715 | +20.9% | 0.15% | +92.1% |
| Q1 2022 | $107,725,000 | +110.8% | 11,048,765 | +209.2% | 0.08% | +171.4% |
| Q4 2021 | $51,108,000 | -21.3% | 3,573,908 | +10.3% | 0.03% | -17.6% |
| Q3 2021 | $64,940,000 | +8.3% | 3,240,543 | +18.9% | 0.03% | +17.2% |
| Q2 2021 | $59,954,000 | +52.8% | 2,725,197 | +135.9% | 0.03% | +31.8% |
| Q1 2021 | $39,235,000 | – | 1,155,353 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |